A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice

@article{McCaffrey2003APA,
  title={A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice},
  author={Anton P. McCaffrey and Leonard Meuse and Mobin Karimi and Christopher H. Contag and Mark A. Kay},
  journal={Hepatology},
  year={2003},
  volume={38}
}
Hepatitis C virus (HCV) is an RNA virus infecting one in every 40 people worldwide. Current treatments are ineffective and HCV is the leading cause of liver failure leading to transplantation in the United States and Europe. Translational control of HCV is a prime therapeutic target. We assessed the inhibitory potential of morpholino phosphoramidate antisense oligonucleotides (morpholinos) on HCV translation by codelivering them with reporter plasmids expressing firefly luciferase under the… 

Antisense Morpholino-Oligomers Directed against the 5′ End of the Genome Inhibit Coronavirus Proliferation and Growth†

Conjugation of a peptide related to the human immunodeficiency virus type 1 Tat represents a novel method for delivery of antisense morpholino-oligomers that has therapeutic potential for control of coronavirus infection.

Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene expression in human tissue culture cells and a mouse model.

Oligonucleotide-Based Therapeutic Options against Hepatitis C Virus Infection

Progress in oligonucleotide-based HCV antivirals towards clinical application depends on development of nucleotide designs that bolster efficacy while minimizing toxicity, improvement in liver-targeting delivery systems, and refinement of small-animal models for preclinical testing.

Suppression of Hepatitis C Viral Genome Replication with RNA-Cleaving Deoxyribozyme

The DNAzyme and the DNAzyme conjugated nanoparticle system are discussed in detail to demonstrate a successful usage of functional oligonucleotide and its delivery in vivo for further therapeutic application offunctional oligon nucleotides in the treatment of hepatitis C.

Long-term hepatitis C internal ribosome entry site-dependent gene expression mediated by phage φC31 integrase in mouse model

The results indicate that this mouse model provides a powerful tool for accurate and long-term evaluation of potential anti-IRES compounds in vivo, and is utilized to develop a stable, reproducible and easily accessible HCV IRES mouse model.

A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins

Novel chimeric flaviviruses offer opportunities for new insights into HCV replication mechanisms, while potentially facilitating the evaluation of candidate therapeutics in vivo, and appears to contain virus‐specific replication signals that interact with other sites within the viral genome or with viral proteins.

Hepatitis C virus translation inhibitors targeting the internal ribosomal entry site.

An overview of approaches to block HCV IRES IRES function by nucleic acid, peptide, and small molecule ligands is provided andphasis will be given to the IRES subdomain IIa, which currently is the most advanced target for small molecule inhibitors of HCV translation.

Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice.

This study may provide an effective way to interfere with the potential therapeutic target fgl2 gene for fulminant viral hepatitis and other diseases with similar pathological characteristics of microcirculation disorders, including acute rejection of xeno- or allograft transplantation and fetal loss syndrome.
...

References

SHOWING 1-10 OF 32 REFERENCES

Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice.

Hepatitis C virus (HCV) is an RNA virus infecting 1 in every 40 people worldwide. Development of new therapeutics for treating HCV has been hampered by the lack of small-animal models. We have

Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines.

Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes

Investigation of inhibition of HCV gene expression using antisense oligonucleotides complementary to the 5' NCR, translation initiation codon, and core protein coding sequences found them to be the most effective at inhibiting HCv gene expression, and demonstrates that it is feasible to design antisenseligonucleotide inhibitors of translation that do not require RNase H activation.

Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides

The data suggest that HCV gene expression can be inhibited effectively by antisense S‐ODN, and this approach represents a promising perspective for the treatment of hepatitis C.

Antisense Oligonucleotide Inhibition of Hepatitis C Virus (HCV) Gene Expression in Livers of Mice Infected with an HCV-Vaccinia Virus Recombinant

Inhibition of HCV reporter gene expression in this small-animal model suggests that antisense oligonucleotides may provide a novel therapy for treatment of chronic HCV infection.

Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.

The data suggest that HCV gene expression can be inhibited effectively by antisense S-ODN, and this approach represents a promising perspective for the treatment of hepatitis C.

Inhibition of hepatitis C virus (HCV)‐RNA–dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes

Treatment with synthetic stabilized anti‐HCV ribozymes has the potential to aid patients who are infected with HCV by reducing the viral burden through specific targeting and cleavage of the viral genome.

Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA

The results demonstrate that IFN and ribozyme each have a beneficial antiviral effect that is augmented when given in combination.